Amphotericin b and Myelosuppression - a phase IV clinical study of FDA data

Summary:

Myelosuppression is reported as a side effect among people who take Amphotericin b (amphotericin b), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Cytarabine, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Myelosuppression when taking Amphotericin b. It is created by eHealthMe based on reports of 16,256 people who have side effects when taking Amphotericin b from the FDA, and is updated regularly.

What is Amphotericin b?

Amphotericin b has active ingredients of amphotericin b. It is often used in thrush. eHealthMe is studying from 16,275 Amphotericin b users. Check the latest studies of Amphotericin b.

What is Myelosuppression?

Myelosuppression (a decrease in the production of blood cells) is found to be associated with 541 drugs and 210 conditions by eHealthMe. Check the latest studies of Myelosuppression.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

16,256 people reported to have side effects when taking Amphotericin b.
Among them, 52 people (0.32%) have Myelosuppression.

Could Amphotericin b cause Myelosuppression?

Among these 52 people:

How long have people been on Amphotericin b when they have Myelosuppression? *

What is the gender of people who have Myelosuppression when taking Amphotericin b? *

female: 40 %
male: 60 %

What is the age of people who have Myelosuppression when taking Amphotericin b? *

What are other drugs people take besides Amphotericin b? *

Cytarabine: 11 people, 21.15%
Vancomycin: 10 people, 19.23%
Prednisolone: 8 people, 15.38%
Cyclophosphamide: 8 people, 15.38%
Piperacillin And Tazobactam: 7 people, 13.46%
Meropenem: 7 people, 13.46%
Ondansetron: 6 people, 11.54%
Voriconazole: 6 people, 11.54%
Amlodipine: 6 people, 11.54%
Mercaptopurine: 6 people, 11.54%

What are other side effects people have besides Myelosuppression? *

Fever: 20 people, 38.46%
Febrile Neutropenia (fever with reduced white blood cells): 12 people, 23.08%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 12 people, 23.08%
Drug Ineffective: 12 people, 23.08%
Septic Shock (shock due to blood infection): 7 people, 13.46%
Leukopenia (less number of white blood cells in blood): 7 people, 13.46%
Rashes (redness): 7 people, 13.46%
Fungal Infection: 7 people, 13.46%
Thrombocytopenia (decrease of platelets in blood): 7 people, 13.46%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 7 people, 13.46%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 8 people, 15.38%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 11.54%
T-Cell Type Acute Leukaemia (a form of cancer of the white blood cells): 5 people, 9.62%
Fungal Infection: 4 people, 7.69%
Fever: 4 people, 7.69%
Pneumonia: 3 people, 5.77%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 5.77%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 3.85%
Cryptococcal Cutaneous Infection (infection caused by the encapsulated yeast cryptococcus neoformans): 2 people, 3.85%
Meningitis Coccidioides (fungal inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 2 people, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Amphotericin b and have Myelosuppression?

- Check whether Myelosuppression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amphotericin b:

Amphotericin b (16,275 reports)

Myelosuppression treatments and more:

Myelosuppression (18,470 reports)

Browse all side effects of Amphotericin b:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Myelosuppression:

Myelosuppression (541 drugs)

Browse all the conditions that are associated with Myelosuppression:

Myelosuppression (210 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amphotericin b (the active ingredients of Amphotericin b) and Amphotericin b (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.